NanoViricides Inc. (NNVC): Earnings per share for the last twelve months

Corporate company logo of NanoViricides, Inc. (NNVC)

NanoViricides, Inc. (NNVC) develops nanotechnological antiviral agents, where the success of a single product could fully cover R&D costs and generate colossal profits. Patent protection of innovations creates reliable asset value prior to the emergence of stable cash flow. Demand is increasing due to global healthcare needs. The 12-month net income per share trend shows that the metric stands at -0.41.

NanoViricides, Inc. (NNVC) - Net earnings per share (EPS TTM) from 07/04/2022 to 11/14/2026

Financial and market metric breakdowns for NanoViricides Inc. (NNVC)

- stock price and consensus target price:
Stock Price NanoViricides Corp|NNVC - Analyst Median Target
- stock exchange capitalization data:
Market Value NanoViricides, Inc.|NNVC - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share NanoViricides|NNVC - Book Capitalization|Market Value to Book Value Ratio nanoviricides.com|NNVC - Company Total Asset Base
- debt obligations and liquidity statistics:
Debt to Equity NanoViricides, Inc.|NNVC - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital NanoViricides Corp|NNVC - Company Aggregate Debts|Debt to Book Capitalization Ratio NanoViricides, Inc.|NNVC - Company Long-Term Indebtedness|Company Short-Term Debt NanoViricides|Quick Liquidity Indicator nanoviricides.com
- earnings and valuation multiples indicators:
NNVC - Company Net Income|Projected Future Earnings NanoViricides, Inc.|NNVC - Business Payback Period|Future Price to Earnings NanoViricides Corp|NNVC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple NanoViricides, Inc.|NNVC - Operating income before deduction of amortization|Net earnings per share (EPS TTM) NanoViricides|NNVC - Net earnings per share for the last 12 months|Quarterly EPS earnings growth nanoviricides.com|NNVC - Expected net earnings per share growth this year|Earnings growth forecast for next year NanoViricides, Inc.
- sales and revenue data:
NNVC - Company Sales Volume|Projected Sales Volume NanoViricides Corp|NNVC - Price to Sales|Price-to-Projected Revenue Ratio NanoViricides, Inc.
Analysis of all company metrics:NNVC - nanoviricides.com
Mass-produced product of NanoViricides Inc.

The complexity of biosynthesis and the prolonged certification process for nanotechnological pathogen traps define the capitalization specifics of NanoViricides, Inc. (NNVC). An analysis of the net income per share over the last 12 months allows for an assessment of this strategy's effectiveness without quarterly delays. This metric measures the final profit allocated per share, stripping the result of the impact of issuance. The indicator's dynamics reveal phase transitions from investment euphoria to market capitulation. This asset is categorized as a high-risk venture security.

Direct competitors

Gilead Sciences, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Therapeutics Inc CDTX|Novavax (NVAX) - Earnings per share for the last twelve months|CureVac NV - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Net earnings per share (EPS TTM) Vir Corp|Earnings per share for the last twelve months SIGA Technologies, Inc. (SIGA)|Net earnings per share for the last four quarters emergentbiosolutions.com|Earnings per share for the last twelve months Atea Pharmaceuticals, Inc. AVIR|IVVD: Earnings per share for the last 12 months|Enanta - Net earnings per share (EPS TTM)|INO - Net earnings per share (EPS TTM)|HilleVax, Inc. (HLVX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months KLRS|Earnings per share for the last twelve months Dyadic International Inc|Net earnings per one share for the last twelve months Talphera Inc TLPH|Net earnings per share for the last 12 months COCP (Cocrystal)|Earnings per share for the last twelve months TRAW (trawspharma.com)|Net earnings per share (EPS TTM) DWTX (Dogwood Therapeutics)|Net earnings per share for the last four quarters qualigeninc.com (QLGN)|ALVR - Earnings per share for the last twelve months|Earnings per share for the trailing year VBIV (VBI Vaccines Inc.)|VIRI: Net earnings per share (EPS TTM)|VXRT - Net earnings per share for the last four quarters